Press "Enter" to skip to content

Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018

GSK retains No 1 position, as Novartis overtakes J&J to take 2nd place. Takeda jumps 10 places to 5th.

Original source:

Also Read:   Biocon Biologics appoints M.B. Chinappa as CFO